Estimated reading time: 2 minutes
Background
Credit facility limit:
$5,000,000
General description: Pharmaceutical company
State of formation:
Delaware
Customer type:
Fortune 500 drug wholesale companies
Issue
This Delaware-based, private equity owned company; provides women’s wellness pharmaceutical products with facilities in North Carolina and Tennessee. To date, the company has been well capitalized and buoyed through private equity. However, since their relatively new wellness product gained acceptance in both the medical industry and customer market, the company is undergoing high product demand and therefore, staggering revenue growth. As a result, the company was in search of non-dilutive, short-term working capital to fund its accelerated corporate development.
Proposed Solutions
United Capital Funding (“UCF”) proposed an asset-based, accounts receivable factoring facility; which delivered a flexible and adaptable form of working capital sufficient enough to grow along with their current increasing customer demand. Through this form of financing, the company was able to:
- Secure an adequate credit facility collateralized by their accounts receivable; then they could have achieved by leveraging their current balance sheet under a traditional revolving line of credit.
- Increase liquidity to support customer demand without raising additional dilutive private equity capital.
- Expand at an integral part of the company’s life cycle without restrictive covenants.
- Decrease their overall Days Sales Outstanding by working with an institution that has been in business for 25 years supporting its customers with professional AR management services.
- Reduce senior management’s time and energy on cash flow management and therefore, allowing greater attention on growing revenues and ensuring customer satisfaction.
Conclusion
The company accepted UCF’s proposed terms and was successfully underwritten and approved. Given the growing valuation of shareholder equity, the relationship between UCF and its client will prove to be less expensive than raising additional private but dilutive capital.
Due to the effect of rising revenue, stable gross margins and relatively flat fixed expenses, our working capital solution will work to maximize shareholder value. By working with UCF, our customers almost always gain the additional working capital necessary to support continued growth and seek additional business in new verticals and markets.
Connect with United Capital Funding